Cite
HARVARD Citation
Ward, R. et al. (n.d.). 253 Anti-TIGIT antibodies require enhanced FcγR co-engagement for optimal T and NK cell-dependent anti-tumor immunity. Journal for immunotherapy of cancer. p. A153. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ward, R. et al. (n.d.). 253 Anti-TIGIT antibodies require enhanced FcγR co-engagement for optimal T and NK cell-dependent anti-tumor immunity. Journal for immunotherapy of cancer. p. A153. [Online].